Covid-19: The daily dose (July 7, 2021)

PT Jyothi Datta | Updated on July 07, 2021

We curate for you all the Covid-19-related developments and stories of the day worth reading

# The Russian Covid-19 vaccine picks up one more partner to make Sputnik V in India, Morepen labs. Stock runs up 9 percent on the news.

Morepen starts test production of Sputnik V

# And staying with Covid-19 vaccine tie-ups, Dynavax Technologies Corporation and Biological E Ltd (BE), inked a commercial supply agreement for Dynavax’s adjuvant, used in the vaccine.

Dynavax, Biological E ink agreement for Corbevax

# A study finds that 600-odd civil society organisations used all their resources to provide relief to people during the first and second waves of Covid-19, even as Governments struggled. Tragically, about 50 organisations reported deaths too.

How CSOs chipped in as local communities grappled with Covid second wave

# The Sutra model of simulation expects the third Covid-19 wave to have less of an impact, provided, there is no nasty variant on the horizon.

‘Third wave of Covid-19 will not be big if immune-escape mutant does not emerge’

# While some countries talk of a booster dose, Health authorities in India say, a booster dose of Covaxin is still at the scientific ideation stage - as it is not very clear how long the immunity from vaccines will last.

Booster dose is not yet under consideration, says ICMR chief

# On the downward trend, India’s active cases decline to 4,64,357, the lowest in over 100 days.

Covid-19: India records lowest daily rise in 111 days at 34,703

Published on July 07, 2021

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor

You May Also Like